Relation is a forward-thinking biotech startup, founded in 2019, that is making waves in the Biotechnology and Pharmaceutical industries. Headquartered in the United Kingdom, the company focuses on developing transformational medicines with cutting-edge technology at its core.
Guided by its slogan, "Discovering the relationships at the heart of biology to cure disease," Relation aims to revolutionize the understanding of human biology. By harnessing single-cell and multi-omics measurements alongside machine learning, the company seeks to discover novel therapies to address some of the most devastating diseases. Its unique Lab-in-the-Loop integrates these technologies to identify drug targets and develop breakthrough medicines.
In its latest venture capital round, Relation secured a $55.00M Late VC investment from Novartis on 01 December 2025. This substantial backing underscores the strong investor confidence in Relation's innovative approach and its potential to disrupt traditional healthcare paradigms.